Prostate-specific antigen (PSA) kinetics following focal low-dose-rate (LDR) brachytherapy for low-intermediate risk prostate cancer
USANZ ASM ePoster Library. Harkin T. 02/26/23; 375572; 123
Dr. Timothy Harkin
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}